Removing Silicone Artifacts in Diffusion-Weighted Breast MRI by Means of Shift-Resolved Spatiotemporally Encoding
Eddy Solomon1, Noam Nissan2, Rita Schmidt1, Edna Furman-Haran3, Uriel Ben-Aharon4, and Lucio Frydman1

1Chemical Physics Department, Weizmann Institute of Science, Rehovot, Israel, 2Biological Regulation Department, Weizmann Institute of Science, Rehovot, Israel, 3Unit of Biological Services, Weizmann Institute of Science, Rehovot, Israel, 4Breast Surgery Unit, Meuhedet Clinic, Ashdod, Israel

Synopsis

A new ADC-mapping methodology based on SPatio-temporal ENcoding (SPEN) was applied to augmented breasts, organs possessing multiple spectral components. SPEN provides a robust single-shot alternative to echo-planar-imaging (EPI) in terms of overcoming B0-inhomogeneities, while being able to resolve—and thereby suppress—the contributions of different chemical sites. Diffusion SPEN measurements were carried out at 3T on healthy volunteers with silicone-implant augmentation and compared against SE-EPI counterparts, confirming SPEN’s ability to yield more reliable ADC maps, free from the dominant silicone signal contributions, in a single shot. This opens new screening possibilities for cancer detection in breast augmented patients.

Introduction

There is a growing need for imaging breasts with silicone implants, driven by augmentation procedures for cosmetic and cancer-related reconstruction purposes [1]. While the silicone implant’s integrity accounts for the main radiological concern of these patients, breast cancer detection and diagnosis remain an important need. A promising non-invasive method to diagnose breast cancer is diffusion-weighted MRI (DWI) [2], a diagnosis based on the fact that cancerous tissues exhibit lower apparent diffusion coefficient (ADCs) than normal fibroglandular tissue or benign lesions [3]. Diffusion measurements require fast imaging techniques, exhibiting reduced sensitivity to motional effects. In most cases the method of choice is spin-echo echo planar imaging (SE-EPI). Still, SE-EPI is prone to display artifacts, particularly when applied to the examination of challenging organs like silicone-implanted breasts. Here the presence of water-, silicone-, and fat-rich regions results in chemical shift artifacts and field heterogeneities, leading to spurious replicas that may confound the radiological interpretation [4]. In this work we explore the use of a DWI imaging methodology based on SPatio-temporal ENcoding (SPEN). This single-shot technique has proven as a highly robust alternative in terms of overcoming B0-inhomogeneities and heterogeneous chemical environments [5-6]. An important advantage of SPEN rests in its ability to resolve—and thereby, if needed, suppress—the contributions of different chemical sites without any changes in the basic imaging-oriented pulse sequence [7]. The purpose of this study was to explore the application of SPEN’s strategies to acquire reliable ADC maps of fibroglandular tissue in silicone implanted human breasts, whose images have been freed from the dominant silicone signal contributions.

Methods

This study was approved by the Institutional Review Board of the Wolfson Medical Center (Holon, Israel) and included seven healthy volunteers with different sizes of silicone implants and of fibroglandular tissue. Axial images were acquired at 3 Tesla (T) on a Siemens TrioTIM scanner using a four-channel bilateral breast coil. The MRI protocol included a T2-weighted turbo spin-echo (TSE) followed by DWI acquisitions of twice-refocused SE-EPI and by SPEN DWI with fat suppression using d=17 ms, ∆=35 ms and n=7 nominal b-values in the range: 0-750 (s/mm2). The spatial resolutions of both SE-EPI and SPEN experiments were 2.0x2.0x2.5 mm3. The total scan durations (per slice) were 180 ms and 277 ms for DWI SPEN and SE-EPI, respectively.

Results

While SPEN’s image retrieval process does not require Fourier processing, it follows that FT along the SPEN/time acquisition axis, will yield the sample’s chemical shift spectrum [7]. In this way SPEN provides the basis for single-scan spectroscopic imaging; individual contributions arising from each chemical resolved site can then be manually isolated (or removed). Figure 1a shows a TSE multi-shot scan of a healthy volunteer including the silicone implant, the fibroglandular tissue, and the fatty tissue. Following SPEN’s spectral filtration procedure, we were able to selectively separate the fibroglandular tissue (Fig. 1c) and the silicone implant (Fig. 1d) – both from the same single-scan information. Additionally, utilized in Figure 1 was SPEN’s capability to “zoom” on a single breast, while avoiding folding. Figure 2 shows a representative scan of a healthy volunteer, presenting a TSE image (Fig. 2a), as well as anatomical b-zero images (Fig. 2b) and ADC maps (Fig. 2c) delivered by DWI SE-EPI and by SPEN, respectively. To avoid folding artifacts the FOV used in the SE-EPI was chosen to cover the whole body, whereas in the folding-free SPEN scans the FOV could be reduced to half this size. b-zero images afforded by SE-EPI show a noticeable chemical shift displacement artifact of the silicone implant, which together with a sizable ghost of both the water and silicone signals (yellow arrows in Fig. 2b) appear below the fibroglandular tissue. Under similar conditions SPEN succeeds to deliver images that are significantly less influenced by ghosts, showing the fibroglandular tissue in its right location and a considerably weaker silicone contribution. Analyses of diffusion values measured in breast ROIs (red circled ROIs indicated in Fig. 2c), revealed no significant differences between the ADCs derived from SE-EPI and from SPEN (SE-EPI ADC =1.57±0.18 x10-3 mm2/s, SPEN ADC =1.56±0.12 x10-3 mm2/s, tailed p = 0.16).

Conclusions

This study explored the use of SPEN–based strategies incorporating ADC measurements in the presence of silicone implant. This includes single-scan images that are less affected by field inhomogeneities than SE-EPI’s counterparts, as well as SPEN’s built-in capacity to separate multiple spectral contributions without demanding additions or modifications to the original single-scan 2D imaging sequence, thereby opening new screening possibilities for the identification of malignancies in breast augmented patients.

Financial support

EU, Kimmel Institute and Perlman Family Foundation.

Acknowledgements

No acknowledgement found.

References

[1] Stoblen F et al. Insights Imaging 2010;1:93–97. [2] Sharma U et al. NMR Biomed 2009;22: 104–113. [3] Guo, Y et al. J Magn Reson Imaging. 2002;16:172-8. [4] Farzaneh F et al. Magn Reson Med 1990;14:123–139. [5] Schmidt R et al. Magn Reson Med. 2013;70:382-9. [6] Solomon E et al. Magn Reson Med 2015; 73:2163–2173. [7] Tal A et al. J Magn Reson 2007;189:46–58.

Figures

Figure 1. Axial single augmented breast slice with silicone implant. (a) Multi-shot TSE image showing the boundaries of the silicone implant, the fibroglandular tissue, and the fatty tissue (yellow arrows). (b) Original SPEN image before spectral filtration. (c, d) Chemically resolved single-shot SPEN images of fibroglandular tissue and silicone, respectively.

Figure 2. Comparison between axial anatomical slices (left and middle panels) and ADC maps (right panel). (a) Multi-shot TSE image. (b) Anatomical single-shot images illustrating with yellow arrows residual silicone and ghosted fibroglandular signals. (c) ADC maps arising from twice-refocused SE-EPI (upper panel) and from SPEN (lower panel) sequences.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
2733